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 PROGRAM REPORT 
Dr. Leon N.D. Potgieter, Assistant Director of the Center of Excellence in Livestock 
.. Diseases and Human Health 
It is my privilege to report 	on yet another productive year by the Center of
.. Excellence in Livestock Diseases and Human Health for 1999-2000. Once again the 
Center has met most of its objectives admirably (see tables 1 and 2). The return of the 
State's investment in the Center was almost six fold, a record (see "Funding Levels" 
.. below). The number of scientific communications in the form of refereed 
pllbUcations by Center-based investigators continues to be excellent (this year an 
average of 5.24 per participant). Research results are disseminated to fellow scientists 
.. in prestigious, refereed international journals and to stakeholders in popular journals and 
magazines distributed regionally and nationally. I am particularly impressed by the 
numerous invitations extended to several faculty in the Center to make
.. keynote/plenary presentations at nationaVinternational scientific meetings. They 
include Drs. D.A. Brian, B.T. Rouse, H.M. Schuller and T.W. Schultz. 
This report features the accomplishments and activities of investigators and 
.. 
.. 
research teams that constitute the core of the Center. Their achievements serve a crucial 
function in promoting the College of Veterinary Medicine, the Institute for Agriculture 
and the University of Tennessee. Furthennore, they continue to ensure that the Center 
.. 
maintains its strong competitive position and contribute to the fiscal health of our 
research environment. The report endeavors to emphasize the strength of the Center and 
give a clear indication ofhow it meets its objectives . 
.. 

Accomplishments 

The accompHshments and activities of most core laboratories in the Center 

are summarized in this report in a manner that can be comprehended by a wide 

readership. It is evident from these synopses that the Center: 

.. 1. Improves the quality ofhuman life by improving animal health . 

2. 	 Augments livestock disease research capabilities in the Institute of 
Agriculture. 
3. 	 Identifies and characterizes laboratory and animal models of important 
human diseases. 
4. 	 Studies animalIlaboratory models for better understanding of human 
health.
- 5. 	 Studies the mechanisms of disease development and characterizes 
causative agents ofcommon diseases important to the State ofTennessee. 
.. 6. 	 Improves the capabilities of the College of Veterinary Medicine, the 
College of Agricultural Sciences and Natural Resources and the 
Agricultural Experiment Station to manage these diseases. 
.. 	 7. Improves the facilities to enable the College of Veterinary Medicine to 
study more effectively infectious and toxic diseases ofanima1s. 
8. Disseminates through the Extension Service practical information required 
.. to reduce the incidence oflivestock diseases . 
9. 	 Develops new strategies for the prevention ofdisease. 
-

2 
-

-

10. Improves facilities and expertise to enhance research training. 
11. Develops innovative approaches to the treatment ofhuman diseases. 
Research Funding 
-
-
An important goal of the Center of Excellence in Livestock Diseases and Human 
Health is to support researchers and to promote research by a variety of mechanisms. 
State fiscal restraints for several years have restricted our ability to recruit and hire 
competitive researchers. The Center has had a significant impact over the last two 
years in recruitment of researchers with ongoing research programs. The existence 
.. 
of the Center and its ability to contribute to start-up packages has made the 
difference in these recruitment efforts. The Center of Excellence emphasizes the 
following six specific areas: Infectious Diseases/Population Medicine, Toxicology, 
.. 
Reproduction, Host Defense, Molecular Genetics and Carcinogenesis. Each 
participant contributes to at least one of these areas of emphasis. The Center's 
.. 
underlying philosophy is to enhance the capacity of young or new investigators to 
.. 
-
compete for extramural funding and to assist established researchers in maintaining 
extramural support. The Center does not serve as a primary source of research funding 
for faculty. The main criteria used for funding proposals include scientific merit, 
likelihood of leading to extramural funding and relevance to the Center's objectives. 
Proposals submitted to the Center for funding are reviewed by the Research and Graduate 
Programs Advisory Committee. The latter has one representative from every department 
of the College ofVeterinary Medicine and is chaired by pro Hildegard Schuller. 
The following projects were supported this past year by the Center: 
.. Dr. Joe Bartges. Comparison of 24..hour urinary excretions of total 
glycosaminoglycans, individual glycosaminoglycans, citrate, and sulfate 
in the development ofurinary calculi. 
- Dr. David Bemis. Antibody response to Pasteurella multocida toxoid expressed 
as a recombinant fusion with Bordetella bronchiseptica fimbrial protein . 
.. 
Dr. David Brian: How two terminal genetic structural elements regulate 
replication of the corona virus RNA genome. 
Dr. Hugo Eller. Evaluation of a bovine placentome culture system for tumor 
growth . 
.. 
Dr. James Godkin. Retinoids in oocyte maturation and embryonic development. 
.. Dr. Alan Mathew. Effects of antibiotic management on shedding and resistance 
patterns ofSalmonella typhimurium in swine. 
.. Dr. Michael McEntee. Effect of polyunsaturated fatty acids on the development 
ofprostatic cancer. 
-
Dr. Jack Oliver: Pathophysiological studies of tall fescue toxins in cattle. 
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Dr. Steve Oliver: Identification and characterization of Streptococcus uberis 
virulence factors. 
Dr. Sharon Patton. A rapid test for the diagnosis of Toxoplasma gondii. 
-
Dr. Barry Rouse: Macrophage dendritic cell interaction during immune
- induction by DNA vaccines. 
-
Dr. Hildegard Schuller: Growth control by beta-adrenergic receptors in breast 
cancer cells. 
-
Dr. Terry Schultz: Molecular size and shape considerations for xenoestrogens. 
Dr. Carla SommardabL Chromosomal localization of modifier genes that vary 
the phenotypic expression of the orpk gene between the FVBIN and C3H 
- mouse inbred genetic backgrounds; a mouse model for polycystic kidney 
disease. 
- Dr. Patricia K. Titbof. Components of cigarette smoke augment arteriosclerosis 
by a mechanism that involves the arachidonic acid cascade. 
Additionally, COE funds were distributed to Drs. Xuemin Xu and Hwa Chain Wang as 
part ofa "start-up" package approved during recruitment ofthese investigators. 
- Equipment and Facilities 
Requests from 14 investigators for 18 pieces of equipment were funded by the 
Center of Excellence this past year. Researchers benefiting from the Center grants were 
- Drs. Henry S. Adair, Joseph Bartges, David Brian, Dennis Geiser, James Godkin, Alan 
Mathew, Jack Oliver, Stephen Oliver, Barry Rouse, Hildegard Schuller, Terry Schultz, 
Carla Sommardahl and Hwa-Chain Wang. Criteria considered in the allocation of these
- funds included justification of need, equipment availability in adjacent laboratories, and 
the number of investigators who may benefit. The latter is ofparticular importance; i.e. 
whether these pieces of equipment could be used in a "core" role benefiting as many 
researchers as possible. 
Renovations funded by the Center of Excellence include extensive repair and 
renovation of a walk-in coolers in A329A and A307 laboratories in the Veterinary 
- Teaching Hospital. These coolers are used primarily by investigators participating in the 
COE. Similarly, repair and maintenance of several pieces of research equipment was 
funded by COE funds. This included an ultracentrifuge and the transmission electron 
microscope. 
With support from the Center of Excellence, Dr. Hildegard Schuller and other 
COE participants secured a substantial equipment grant from NIH. This grant supported 
- the purchase of a Fascan-Cell Sorter which will be used for basic and clinical research. 
Matching funds provided by the Center was critical in the success of this application. It 
-
will greatly enhance the research capacity ofthe Center. 
-
-
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Research Training 
The College of Veterinary Medicine funds at least 10 positions for Ph.D. training 
of students with a professional medical degree. Some of these positions are based in the 
-
Department of Pathology (as part of their residencylPh.D. program) and some are 
awarded without restriction. Most of these students become linked with Center of 
Excellence faculty. These young investigators significantly bolster the achievements of 
the Center. Faculty benefiting from these graduate students include Drs. Brian, Tithof, 
- Schuller and Wang. 
In addition, The University ofTennessee's College of Veterinary Medicine is one 
ofthe few colleges ofveterinary medicine to be chosen as a site for a National Institute of 
-
Health Institutional Training grant. This five-year training grant on the "Molecular and 
Cellular Pathobiology of Environmental Disease" is funded through the National 
Institutes of Environmental Health Sciences. The grant began in 1995 and is funded -
through the year 2000; past year expenditures were $218,931. This training grant is 
-
centered in the Department of Pathology, but also involves scientists from other 
departments as well as important collaborators in the Life Sciences Division at the Oak 
Ridge National Laboratory. Dr. David o. Slauson has been Program Director for the 
grant and Pathology Department Head. The research training sponsored by this NIH 
- grant emphasizes the basic molecular and cellular biology of disease, including 
environmental disease. Three DVM graduate students were supported by these NIH 
funds and worked in the laboratories of COE-associated scientists. They are Drs. Brian
- Jull, Steven Grubbs and Sharon Witonsky. 
- Student Awards 
An important mechanism by which the Center of Excellence promotes biomedical 
research is to provide summer opportunities for veterinary students to do investigational 
- work in research laboratories in the College of Veterinary Medicine. This past year the 
Center funded eight requests from frrst- and second-year students. The students are 
required to provide a summary of their work, which then is entered into a competition 
- judged by Phi Zeta, the veterinary honorary society. This program is very successful. 
Several students presented their work to faculty and staff of the Institute of Agriculture 
(see "Culture for Discovery'') and at national scientific meetings. Numerous manuscripts 
detailing results from work done by these students have been submitted for publication to 
refereed journals. In fact, over the past fIVe years, this program has resulted in 
-
approximately 30 publications in refereed journals, several with the students as 
senior authors. 
-
Personnel Changes 
Dr. G. Michael Shires, Dean and Director of the Center of Excellence in 
Livestock Diseases and Human Health retired at the end of the 1999-2000 fIScal 
-
year. The new Dean of the College ofVeterinary Medicine, Dr. Michael Blackwell, will 
either serve as or appoint a new Director ofthe Center in the near future. 
Recent recruitments of faculty with a significant research focus will benefit 
the Center of Excellence in the future (see discussion on "Funding Levels''). Overthe 
past approximately two years we have recruited seven new researchers that will or are 
-
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contributing to our Center of Excellence. They include Dr. Hwa Chain Wang 
(Comparative Medicine Department) who is well funded by NllI and Dr. Patricia Tithoff' 
(Animal Science) who has received very competitive scores for her proposals and likely 
will be funded by NllI in the future. Dr. Joseph W. Bartges (Department of Small 
-
Animal Clinical Sciences) has received substantial funding from a variety of industry 
sources and the Morris Animal Foundation. 
Dr. David Slauson, head of the Department of Pathology in 1999, was able to 
-
recruit Drs. Xuemin Xu and Mei-Zhen Cui. They brought with them significant research 
funding from NUl (ROI grants), American Heart Association and foundations. Their 
research interests also fall within the Center's focus. Dr. Robert Moore, head of the -
Department of Microbiology, announced the recruitment of Dr. Pam Small from NIIL a 
well-known expert on tuberculosis. She will join the faculty in October 2000 and plans 
to do much of her research in the biosafety level three core facility in the veterinary -
teaching hospital. Tuberculosis is again an emerging disease and Dr. Small's research is 
likely to be highly competitive for extramural funding. 
- Dr. Monica Fann was recruited to fill the position of Associate Director of the 
Office of Laboratory Animal Care. This should have a significant impact in facilitating 
research at the College of Veterinary Medicine. Recently, Dr. Hildegard Schuller, 
-
- interim head of the' Department of Pathology, announced the approval of a search for an 
established researcher who would participate in the Center of Excellence of Livestock 
Diseases and Human Health. 
Funding Levels 
Extramural support for the Center of Excellence increased dramatically this 
- year. Retirements and resignations have affected its growth for several years until this 
past year. Funding for the past ten years has been steady and recently, even declining, 
but expenditures this year are the highest ever, surpassing by about 5300,000 the 
- amount in 1990-91, the previous record. Our investment in recruitment of researchers 
the past two to three years now is coming to fruition (see "Personnel Changes"). The 
State's investment in the Center of Excellence in Livestock Diseases and Human Health 
- remains a healthy one. Extramural funding expenditures this year totaled 53,103,004 
whereas the total funding level of all active grants and contracts supporting the 
Center amounted to 510,863,253. The rate of return of State dollars for the year is 
5.95! 
Our investigators brought in $2,674,287 ofnew extramural funds in the past fiscal 
year (Drs. Godkin, Mathew, McEntee, S.Oliver, Rouse and Schuller - see table 2). Also, 
- I am very encouraged that since the end of the 99-00 fiscal year, several COE faculty 
recently appear to have secured new multi-year funding for COE-related research 
amounting to approximately $2,605,000. They include Drs. Barry T. Rouse, Michael 
- McEntee and Sharon Patton. 
Culture for Discovery 
- In the past, the Center promoted a "Research Day" to showcase the achievements 
of participating faculty and to promote research at the College of Veterinary Medicine. 
Attendance at this event has declined significantly in recent years. It appears that the 
- format of scheduling an entire day or two for this event was not appropriate for local 
-
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participation. The past two years the Center has sponsored regular seminars, posters 
and presentations by participating investigators and students. The program was 
-
advertised University-wide and has been very well attended and received. It seeks to 
foster interest in research and to display the Center's role in promoting research at 
the Institute of Agriculture. 
-
The College hosted six visiting scholars in the "Biomedical Seminar Series" the 
past year. These scholars were selected, in part, to contribute to the Center's research 
emphasis. 
- External Review. 
I look forward to another good year for the Center of Excellence in Livestock 
-
Diseases and Human Health. I am confident that the support provided by the Center 
for some of our promising investigators will constitute the embryogenesis of 
established research programs. I anticipate that the extramural funding and other 
-
benchmarks will make an incremental jump again this year as a result of our 
strategic recruiting over the past two years (see "Funding Levels"). This should 
constitute an opportune time for reviewing our program. Therefore, the periodic external 
-
review ofthe Center is recommended for the coming year. 
-
-
-
-
-
.. 
.. 
.. 
... 
.. 
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~RALIMMmNOLOGYLABORATORY 
Dr. Barry T. Rouse 

Fellows, Staff and Graduate Students: S. Chun, S. Deshpande, S. Kug Eo, U. 

-
Kumaraguru, S. Lee, T. Sobhani, M. Zheng 
Dr. Rouse's research deals with the recognition and interaction of the body with 
-
viral infections. This group has studied herpes simplex virus, an agent that affects the 
-
majority of humans. The virus persists indefinitely in infected individuals, and some 
suffer periodic lesions which are painful and inconvenient. When such lesions occur in 
the eye, they can lead to blindness. Dr. Rouse's laboratory is involved in studies directed 
to understand the mechanisms by which herpes simplex infection causes blindness . 
.. 
-
Dr. Rouse's approach to understanding the interaction between herpes simplex 
virus and the immune system is to exploit model infections such as the mouse system as 
an animal model. Their aim is to understand how cells and molecular events set into pJay 
by herpes simplex virus lead to chronic inflammatory lesions or to resolution of disease. 
Ultimately, it may prove possible to manipulate the host defenses either to achieve 
- protection by vaccines or resolution of injury by substances introduced by gene transfer 
technology and capable of influencing the immune response. 
- In the last year they have used mouse models which have been genetically 
manipulated to cause deficient immune systems and thereby to evaluate whether the 
ocular lesions are the consequence of an autoinflammatory (self-destructive) reaction. 
- Their results do not support the latter hypothesis. Instead the evidence indicates that 
herpes simplex replication in the eye causes the output of molecules called cytokines and 
chemokines which activate certain invading cells of the immune system (T lymphocytes) 
- to release inflammatory substances. This mechanism is referred to as bystander 
activation. Such a mechanism could represent an important component of any chronic 
inflammatory reaction~
-
The other major activity in Dr. Rouse's laboratory is to understand the cell and 
.. 	 molecular events that occur during an immune response to novel DNA vaccines. They 
have identified that a process called "cross priming" is the main event in this process and 
that it is mediated by a "chaperone molecule" bound to a protein (peptide). They are 
-
exploring the use of chaperone-bound peptides as a unique means of vaccination. This 
could have a major impact in the prevention ofviral diseases in people and animals. 
The Center of Excellence supports some aspects of this research which is funded 
- primarily by substantial grants from the National Institutes of Health. Their work has 
generated national and international interest, and the laboratory is recognized as one of 
.. 	 the premier viral immunology programs in the country. Dr. Rouse is one of a very select 
group ofinvestigators in this country holding three RO1 NIH awards simultaneously. 
-

-

-
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-MASTITIS RESEARCH LABORATORY
-
Dr. Stephen P. Oliver. 

Fellows and Staff: R. Almeida, W. Fang, B. Gillespie, M. Lewis, D. Luther, S. Ivey, L. 

-
Coleman. 
Research conducted by Dr. Oliver focuses on mastitis in dairy cows caused by 
-
environmental organisms. Several kinds of bacteria are capable of infecting the udder 
-
causing mastitis. These pathogens invade the udder, multiply there and produce harmful 
substances that result in inflammation, reduced milk production and altered milk quality. 
-
Control ofmastitis is extremely difficult because of the many types and sources ofmastitis 
pathogens that can cause the disease. The National Mastitis Council estimates that mastitis 
costs U.S. dairy producers over two billion dollars annually. In Tennessee, losses due to 
-
mastitis may exceed $25 million annually. Thus, mastitis in dairy cows is likely the most 
costly disease affecting dairy producers in Tennessee, the U.S., and throughout the world. 
Dr. Oliver was the first to show that mastitis in pregnant dairy heifers occurred 
frequently near calving and that many of these infections persisted into early lactation. His
- research has resulted in a simple, effective and inexpensive method for controlling mastitis 
in heifers. Intra-mammary antibiotic infusion before calving, was shown to be an 
effective procedure for: 
- 1) eliminating many infections in heifers during late gestation 

2) reducing the prevalence ofmastitis in heifers during early lactation 

3) for reducing the prevalence ofmastitis in heifers throughout lactation. 

- . He documented that a return of $12..$20 for each dollar spent was possible using this 
approach. 
- Several studies over the past 13 years at the UT Dairy Experiment Station involved 
collection ofalmost 200,000 milk samples for microbiological evaluation at intervals before 
calving, during lactation and during the dry period. Data from those studies have been 
- computerized and this mastitis database may be the largest in the world. It now is being 
exploited for retrospective studies and will provide valuable infonnation on the spread of 
-
mastitis pathogens, such as Streptococcus uberis and Streptococcus dysga/actiae, in high­
producing dairy herds. Recently, they evaluated the influence ofmastitis on reproduction in 
Jersey cows and found it profoundly impairs reproduction during early lactation. 
Dr. Oliver has been actively seeking the identification ofvirulence (severity) factors 
produced by certain mastitis organisms (Streptococcus species) and implications of 
immunity to them. In many dairy herds Streptococcus uberis and Streptococcus
- dysga/actiae are responsible for a high proportion of mastitis with varying degrees of 
severity in lactating and non-lactating dairy cows. Strategies for controlling these mastitis 
pathogens are poorly defined and inadequate. This research focuses on: 
- 1) genetic characterization ofStreptococcus uberis and Streptococcus dysga/actiae 
2) characterization of Streptococcus uberis and Streptococcus dysga/actiae with 
-
particular emphasis on factors involved in adherence and invasion into 
mammary epithelial cells 
-
-
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-3) evaluation of immunity after immunization of dairy cows with components of
- Streptococcus uberis and Streptococcus dysgalactiae 
4) effectiveness ofexperimental vaccines to Streptococcus uberis and Streptococcus 
dysgalactiae mastitis during the nonlactating period 
-
Dr. Olivers research group has determined that Streptococcus uberis and 
Streptococcus dysgalactiae readily adhered to and invaded cells lining the bovine udder. 
-
Chronic infections then may develop, and their intracellular location may protect these 
-
bacteria from anti-microbial drugs and host defense mechanisms. Mastitis pathogens 
cultured in the presence of mammary epithelial (lining) cells in the laboratory synthesize 
proteins not detected when bacteria are cultured alone. These unique proteins likely are 
-
involved in virulence of bacteria, including their capacity to adhere and invade mammary 
epithelial cells. Thus, culture of mastitis pathogens in the laboratory in the presence of 
-
mammary epithelial cells may result in expression of bacterial virulence factors similar to 
that which occurs in the animal. This important discovery will be exploited for the 
development ofvaccines and management ofmastitis. 
Dr. Oliver's expertise in mastitis and milk quality has led also to a new research 
- initiative in food safety. The primary goal is to provide comprehensive infotmation on the 
occurrence and distribution of Salmonella, Escherichia coli 0157:H7, and Campylobacter 
jejuni in bulk tank milk, feces ofcull dairy cows and the environment in dairies. Antibiotic 
- resistance patterns and molecular characterization of foodborne pathogens is also being 
done. 
Dr. Oliver has increased the awareness of scientists, extension specialists, dairy
- producers and phannaceutical companies of the importance of environmental pathogens in 
bovine mastitis. Furthermore, he has discovered fundamentally important infotmation that is 
critical for controlling the heterogeneous organisms that cause mastitis. Dr. Oliver's
- research philosophy is to design and conduct innovative and useful studies and to report to a 
wide variety of constituents. The ultimate goal ofthis research is to enable dairy producers 
in Tennessee, the U.S., and throughout the world to enhance the quantity and quality ofmilk
- produced and thus reduce the economic impact ofmastitis. 
-
Dr. Oliver's research has been supported for several years by the Center of 
Excellence, but his primary funding has been derived from substantial grants from 
foundations, FDA and the phannaceutical industry . 
.­
-

-

-

-
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VIRUS MOLECULAR BIOLOGY LABORATORY 
Dr. David A Brian 

Fellows and Graduate Students: Dr. S. Senanayake, Dr. K. Nixon, Dr. A. Ozdarendelli, 

G.D. Williams, S. Raman, C. Gay, H. Wu. 
Dr. Brian's interest in basic molecular biology of viruses has resulted in -
discoveries of a fundamental nature for which his laboratory has received national and 
international recognition. His research focuses on coronaviruses which cause of some of
- the most costly respiratory and gastroenteric diseases of livestock and fowl, and disabling 
diseases ofpeople. Efforts to control coronavirus infections have been frustrated by three 
major obstacles: 
- 1. 	 An incomplete understanding ofhow coronaviruses replicate and persist in 
animals. 
2. The ability of coronaviruses to rapidly mutate into new pathogenic
- variants. 
3. The generally weak immune responses in animals to coronavirus 
vaccination and the logistical problem of inducing protective mucosal 
- (local) immunity in the vulnerable newborn. 
-
-
The primary research focus in Dr. Brian's laboratory is the molecular biology of 
coronavirus replication. With funding from the USDA and the NIH, and modest support 
from the Center of Excellence, they are making an intense effort to understand how five 
separate genetic elements in the coronavirus function to regulate production of viral 
proteins and progeny virus. Research is being done also on a sixth genetic region, a hot 
spot for variability, in an effort to understand the determinants of this process. Genetic 
-
recombination (blending) at this site is a mandatory step used by the virus in the 
generation of messenger molecules that encode portions of the virus' genetic material. It 
is anticipated that information from these studies will significantly impact the design of 
-
new therapeutic strategies. 
Ofspecial interest is how a newly discovered element at one end ofthe virus gene 
-
regulates replication of the genetic material. The element is a tRNA-like folded structure 
(a pseudoknot), that may regulate virus replication by incorporating a cellular protein in 
the virus replication machinery. Therapeutic interruption of such a virus-protein 
interaction may lead to a cure of virus infection. Interestingly, one candidate protein in 
this interaction is histidyl tRNA synthetase, a factor (autoantigen) in the human disease 
polymyositis.
- Dr. Brian's laboratory has also discovered a small genetic variant of the bovine 
coronavirus (a viral minigenome) that replicates in the presence of "normal" virus. This 
minigenome is being experimentally engineered to carry many kinds ofpotential antiviral 
-
molecules into cells. One molecule is an enzyme (a ribozyme) designed to destroy the 
gene on which the virus depends for replication (the polymerase gene). This novel 
therapeutic approach would, in theory, cure a virus-infected cell without killing it. 
-
-
-
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ANTIBIOTIC RESISTANCE LABORATORY 
Dr. Alan G. Mathew 
Staff and graduate students: R. Clift, S. Chatt~ D. Arnett, P. Cullen, P. Ebner, K. 
Gamer, G. Pulliam 
Antimicrobial compounds are commonly used in US livestock systems. -
Therapeutic use of antibiotics continues to playa major role in combating disease 
organisms, while subtherapeutic use in feeds increases animal performance, decreases the 
numbers of infectious organisms in the environment, and lowers the prevalence of -
organisms causing foodbome illness in humans. 
-
- In contrast to the above benefits, some evidence suggests that agricultural use of 
antibiotics may be partly responsible for the emergence of drug-resistant bacteria, which 
in turn may decrease the efficacy of similar products used in human medicine. However, 
little information is available on strategies for controlling of antibiotic-resistant 
organisms. In particular, almost no information is available with respect to modern 
livestock production facilities, management, environmental conditions, or drug therapies 
that affect resistance in organisms. Because resistance may be transferred to bacteria 
from a variety of resistant bacteria and associated hosts, it is important that factors 
involved are characterized so that more effective control strategies can be formulated. 
A primary research focus of Dr. Mathew's group is to characterize genetic factors 
that lead to antibiotic resistance in animal and human pathogens. They also are
- investigating how different uses of antibiotics in livestock production affect antibiotic 
resistance patterns, concentrations, and shedding of foodbome pathogens. They hope to 
determine the most effective antibiotic therapies and husbandry practices to maintain 
- animal health, while at the same time limiting prevalence of foodbome pathogens and 
antibiotic resistance ofmicroorganisms in livestock. 
- Recent work by the group has included a pioneering microbiological survey of 
swine farms that used or excluded antibiotics in the animals. They determined that 
pathogenic bacteria from farms that excluded antibiotics were more sensitive to
- antibiotics. However, resistant isolates occurred on both farm types, and young, recently 
weaned animals from all farms harbored the greatest number of resistant isolates. This 
may indicate that stresses associated with weaning affect bacterial antibiotic resistance 
patterns, regardless ofwhether antibiotics were used on the farm. 
-
Dr. Mathew investigated also the effects of antibiotic treatment regimens on 
resistance patterns ofE. coli and Salmonella bacteria in pigs. They inoculated pigs with a 
swine pathogen (K88 E. coli) and a foodbome pathogen (Salmonella typhimurium) and 
then treated with aminoglycoside, sulfonamide, and beta lactam antibiotics using various 
dosing schemes. Dosage methods, dosage levels and rotation with dissimilar antibiotics 
affected the genesis ofresistance. 
-
-
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-Another important discovery was that E. coli associated with livestock became 
-
resistant much more quickly than Salmonella in the same host, possibly indicating a 
greater ability to acquire resistance elements such as plasmids (R-factors), or a greater 
ability to generate chromosomal resistance elements. This finding will be very important 
-
as we assess the agricultural use of antibiotics and the risks of generating resistance in 
-
foodbome pathogens. They now are characterizing the bacterial resistance elements 
using various DNA-based techniques to determiIle the relative importance of R-plasmids 
and chromosomal elements in the acquisition and persistence ofantibiotic resistance. 
Dr. Mathew is continuing other work to detennine how animal stressors such as -
-
crowding, low sanitation, and temperature stress affect the prevalence of antibiotic 
resistance in Salmonella typhimurium and E. coli in swine. Preliminary data indicate that 
such stressors increase the percentage ofresistant isolates. 
Work with Dr. Stephen Oliver has focused on the development of rapid methods 
- for detection and differentiation of Salmonella variants. This will allow us to detennine 
the origin and reservoirs of those bacterial variants that are most responsible for 
foodbome illness in livestock operations. They have determined that a linked PCR­
- ELISA assay is capable of rapid (less than 24 hours) differentiation of Salmonella 
bacteria from livestock samples. Such techniques will be instrumental in the 
implementation of on-farm Hazard Analysis Critical Control Points (HACCP) strategies 
.. 
for management ofspecific foodbome pathogens. 
Dr. Mathew's research is supported by the Center of Excellence but primary 
- funding for this work is derived from the International Life Science Institute and the 
National Pork Producers Council. 
-
-

-

-

-

-

-

-
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BIOPHYSIOLOGICAL PATHOGENESIS LABORATORY 
Patricia K. Tithof 
Collaborators, Staff and Graduate students: Dr. M. Peters-Golden, Dr. H. Schuller, Dr. 
-
H.C. Wang, Dr. R. Donnell, M. Elgayyar, M.A. Barnhill 
.. Dr. Tithors research program in cardiovascular physiology concerns the effects 
of specific components of cigarette smoke on the biology of blood vessel lining 
-
(endothelial) cells and metabolism of a potent physiological chemical messenger, 
arachidonic acid. The latter is a fatty acid that is present in high quantities in the 
-
membranes of all cells and is a substrate for the production of eicosanoids, a family of 
biologically active lipid mediators. The latter have an important role in several diseases 
including asthma, arthritis, cancer and atherosclerosis. 
Smoking, which greatly augments the process of atherosclerosis, increases the 
risk for heart attack or stroke by as much as 50%. Recent epidemiologic studies indicate 
that a high fish diet or frequent use of aspirin significantly decreases mortality rates due 
to heart attacks in heavy smokers. Fish contains high levels of certain fatty acids, which 
- decrease the availability of arachidonic acid and also inhibit the production of 
arachidonic acid-derived eicosanoids. The protective effects of these fatty acids and 
aspirin against smoking-induced atherosclerosis suggest that components of cigarette
- smoke stimulate the arachidonic acid pathway. However, no previous studies have 
focused on the specific components of cigarette smoke responsible for this effect. 
Several compounds are contained in high concentration within the tar fraction ofcigarette 
-
- smoke. These include methylanthracenes (1,500 ng/cigarette), phenanthrene (362 
ng/cigarette) and benzo( a)pyrene (25 ng/cigarette). Benzo( a)pyrene accelerates the 
development ofatherosclerosis in animal models. 
Endothelial cells form a single cell layer lining the blood vessel wall. Endothelial 
cell death and loss is a critical and important event in the early development of
- atherosclerosis. Loss of the endothelial cell layer results in inflammation of the vessel 
wall, vasoconstriction and clot formation; events important in the development of heart 
attacks and strokes. Previous studies indicate that cigarette smoking increases the rate of
- endothelial cell loss; however, neither the mechanism of cell death nor the specific 
components ofcigarette smoke responsible have been elucidated. 
- These studies indicate that exposure of porcine aortic endothelial cells or human 
coronary artery endothelial cells to these compounds in cigarette smoke causes release of 
arachidonic acid. Furthermore, this release of arachidonic acid is associated with loss of
- endothelial cell viability through stimulation of a process known as apoptosis or 
programmed cell death. Apoptosis induced by these compounds can be inhibited by the 
fatty acid, eicosapentaenoic acid, which exists at high concentrations in fish. These 
- results suggest that methylanthracenes, phenanthrene and benzo( a)pyrene may be 
important components of cigarette smoke that ,augment atherosclerosis through a process 
that involves arachidonic acid-mediated killing ofendothelial cells. 
-
-
-
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Dr. Tithof also has initiated studies to investigate the effects of derivatives of 
nicotine on endothelial cell function. A derivative of nicotine, NNK, plays an important 
role in smoking-induced lung cancer. Recent studies in collaboration with Dr. Hildegard 
Schuller suggest that NNK induces tumor formation by a mechanism that involves 
-
release of arachidonic acid by stimulation of certain cell receptors (beta-adrenergic). The 
finding that NNK binds to beta-adrenergic receptors has important implications 
concerning a potential effect of NNK on the cardiovascular system. Evidence indicates a 
-
role for the beta-adrenergic system in the cause of atherosclerosis because beta­
adrenergic blocking agents prevent endothelial cell injury Beta-adrenergic blockade also 
reduces endothelial cell injury induced by cigarette smoke. -
The effects ofNNK on endothelial cell viability were investigated by Dr. Tithofs 
-
- group. NNK, at very low concentrations (100 nM) caused apoptotic cell death of 
endothelial cells. Their results suggest that it was the result of NNK binding to beta­
adrenergic receptors and that the arachidonic acid cascade was involved. 
These studies provide novel findings concerning the effects of specific 
components of cigarette smoke on endothelial cell function and suggest a novel
- mechanism by which cigarette smoke augments atherosclerosis. These studies may 
contribute to the development of effective measures for preventing cardiovascular 
complications in smokers. Moreover, identifying specific components of cigarette smoke 
that augment disease may lead to the development of safer cigarettes. These strategies 
may be particularly important because the incidence of smoking continues to rise, despite 
intensive efforts to educate people about the hazards ofsmoking. 
-
-
-
-
-
-
-
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REPRODUCTION LABORATORY 
Dr. James D. Godkin 
... Fellows, Staff and Graduate Students: Dr. D. Eberhardt, T. Livingston, H. King, S . 
MacKenzie, M. Roberts 
The focus of Dr. Godkin's research group over the past few years has been the 
-
study ofproteins that communicate fetal-maternal interactions and result in the successful 
maintenance of pregnancy. One important discovery was that interferon-tau, a placental 
protein, interacts with the uterus and alters maternal hormonal balance and maintains -
early pregnancy in ruminants such as cattle, sheep, goats, and buffalo. Another focus of 
-
Dr. Godkin's labomtory is reproductive efficiency with respect to the effect of growth 
factors and certain vitamin A-like proteins (retinoid-associated) and their genes on the 
early embryo, ovary, oviduct and uterus . 
... The major current focus of Dr. Godkin's laboratory is on factors that control 
development of the early embryo of domestic livestock. Recently, they made the 
remarkable discovery that treatment of animals with vitamin A-like compounds
... (retinoids), just prior to ovulation, results in improved viability of embryos that then 
develop following fertilization. In addition, his laboratory studies indicated that 
treatment of embryos with retinoids dramatically improved embryonic development. The 
... 
goals of this research are to improve reproductive efficiency through the use of retinoid 
administration procedures, to develop more efficient assisted reproductive procedures and 
to determine the mechanisms by which retinoids affect oocyte (egg) maturation, 
... 
embryonic development and survival. 
.. This research has the potential to improve reproductive efficiency in livestock and 
improve assisted reproductive procedures in humans. It also has an application for the 
preservation ofendangered species . 
... 
... 
A patent application has been filed covering the use of retinoids in assisted 
reproductive procedures with the assistance of the UT Research Corporation. Dr. 
Godkin's research has received support from the Center of Excellence which has been 
leveraged into substantial funding from the USDA's National Research Initiative. 
-
... 
-
... 
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GASTRITIS PATHOGENESIS LADORATORY 
Dr. Frank M. Andrews 
- Collaborators, staff and graduate students: Dr. A.G. Mathew, Dr. C.S. Patton, Dr. J.T. 
Blackford, Dr. A.M. Saxton, Dr. S. Murphy, Dr. J. Collins, Dr. R. Torres-Diaz, M. 
-
Sewell, A. Nadeau 
Dr. Andrews studies the genesis and mechanisms of gastric ulcer development in 
a horse model. Gastric ulcer disease is a common problem in performance horses. The
- latter are commonly fed concentrated high-energy feeds that contain high levels of 
carbohydrates (starches). These carbohydrates undergo fermentation by resident bacteria 
in the stomach that may result in release of by-products such as volatile fatty acids 
- (acetic, butyric, valeric and propionic acids). Previous research in this laboratory 
established that high concentrations of volatile fatty acids are produced in the stomach of 
horses fed high-energy diets. These acids, due to their high lipid solubility, diffuse into 
- the non-glandular gastric cells causing acidification and damage to sodium transport, 
which leads to cellular injury and gastric ulceration. 
- Current studies involve examination of fresh viable non-glandular tissue (most 
susceptible to gastric ulceration) from the stomach of horses. Tissues are placed in an 
Ussing chamber system, which allows measurement of tissue short-circuit current
- (sodium flow) and resistance across the tissue. A decrease in short-circuit current and 
resistance are the first indicators of tissue damage, and precede gastric ulcer formation. 
-
These tissues then are viewed under the microscope after special staining to determine 
the nature and extent of cellular damage. 
Dr. Andrews' research suggests that volatile fatty acids, especially butyric and 
- propionic acids in contact with the stomach lining of horses and in the presence of 
stomach acid (PH = 1.5 and 4.0) leads to damage to cell's sodium transport system, 
-
cellular swelling, irreversible tissue damage and ulceration. These fmdings suggest that 
dietary modification, reducing the formation of these acids, may be helpful in prevention 
or decreasing the incidence of gastric ulcer disease in horses. These results have 
-
implications for several animal species including humans. 
This research is funded by the Grayson-Jockey Club Research Foundation, the 
Comparative Gastroenterology Society and the Center ofExcellence. 
-
-
-
-

-
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TALL FESCUE TOXICITY LABORATORY 
Dr. Jack W. Oliver 

Co-investigators and staff: Dr. R. Linnabary, Dr. E. Schultze and Dr. B. Rohrbach, 

-
L.K. Abney, E.M. Bailey, M. Cottrell and J. Czarra 
Tall fescue toxicosis continues to be the primary grass-related disease in the 
-
United States in terms of economic loss to animal producers, affecting over 8.5 million 
-
beef cows and 700,000 horses. Tall fescue toxicosis is also a costly disease to Tennessee 
cattle producers, resulting in an approximate $100 million dollar annual loss due to 
unrealized production. Tall fescue is an attractive forage species because of its ability to 
withstand drought, poor soil conditions and intensive defoliation from grazing. It is 
grown on more than 34 million acres ofpasture, but 75% of the pastures are infected with -
-
the endophytic-fungus, Neotyphodium coenophialum, at a sixty percent or greater level. 
Most ofthe infested pastures are in the Southeastern United States. 
The endophyte-grass association results in the production of alkaloid toxins 
produced by the fungus or by the plant in response to the fungus. The alkaloids are 
- biologically active causing a decrease in appetite and impaired reproduction and growth 
in animals. Endophyte-infected tall fescue has greater forage and seed productivity than 
the non-infected variety and is more drought tolerant. At the same time, tall fescue 
- toxicosis is a costly disease to animal producers, causing severe reductions in weight 
gains, milk production and fertility. 
- Results of studies by Dr. Oliver's group have established that vascular damage is 
a central event that occurs when herbivores consume infected tall fescue. As a 
consequence of injury to blood vessels, blood flow to tissues is impaired causing 
- localized tissue damage and thereby affecting the function of body systems. The 
abnormalities in blood flow are integrally related to the economic losses encountered by 
the cattle industry in the United States. Dr. Oliver has been examining toxicity associated 
- with purified alkaloids that are suspected of being the primary tall fescue toxins (Le. 
ergine, ergovaline). The long range goal of these studies is to understand how the 
individual toxic alkaloids cause damage to tissues of cattle because little is known 
- regarding which of the alkaloids in tall fescue cause(s) the lesions in this syndrome. 
Studies have been completed on analyses of various parameters of blood and 
- tissues in steers that grazed endophyte-infected tall fescue over a three-year period. 
Markedly suppressed levels of serum copper were recorded in consecutive years, and 
copper deficiency may be the basis of the poor haircoats in these cattle. Gamma globulin 
- (antibody) levels these cattle also were significantly reduced, suggesting that 
immunosuppression is an important aspect of the disease too. This information of tall 
fescue toxicity in cattle will be important in evaluating anti-fescue toxicosis treatments. 
-
Continued research will be focused on the chronic effects of the two important 
alkaloids of toxic tall fescue, ergine and ergovaline. Cattle will be treated with each of 
- these alkaloids to evaluate their effect on the function of a specific blood vessel receptor 
-
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(alpha-2 adrenergic). Dr. Oliver determined that ergo valine administration at the rate of 
0.2 uglkg/hour caused the typical decrease in the hormone (prolactin) in blood that occurs 
in cattle grazing on fungus-infected tall fescue pastures. Since the lining cells of blood 
vessels (endothelial cells) are damaged by exposure to the alkaloids, several 
-
inflammatory mediators associated with endothelial cell injury will be measured in the 
-
serum ofthe cattle that are infused with ergine or ergovaline. 
-
Laboratory studies with isolated bovine endothelial cells or smooth muscle cells, 
grown in culture were treated with various concentrations of ergovaline and ergine. Both 
of these alkaloids are toxic to endothelial cells but ergovaline was considerably more 
potent. Dr. Oliver's results indicate that manipulation of the infection allowing ergine 
production in the plant but elimination of ergovaline presence would be beneficial. The
- ergine is necessary to convey insect resistance to tall fescue and the toxic effect would be 
minimized because the absence of ergovaline. Reducing the toxic effect of ergovaline in 
cattle will allow increased use of tall fescue, a forage with excellent nutrient quality, and 
-
- root development that helps to control soil erosion. Dr. Oliver's research has been 
supported by the Center of Excellence, but his primary support is from the USDA's 
National Research Initiative. 
-

-
-
-
-
-
-
-
-
-
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BIOLOGICAL ACTIVITY TESTING AND MODELING LABORATORY 
Dr. Terry W. Schultz 
Staff and Graduate Students: G. Sinks, B. Gregory, J. Seward, and E. Hamblen 
-
-
Research in the Biological Activity Testing and Modeling Laboratory focuses on 
the development of databases for structure-toxicity modeling and the development and 
validation of such models. The values of structure-toxicity models lie in their ability to 
predict toxic potency from molecular structure. This means that hazard assessment can 
be conducted while conserving time, manpower, resources, and animals. -
Toxic potency is related to the uptake of the toxicant from the environment and its 
- interaction with certain molecular sites of action. Since certain properties (such as 
hydrophobic, electronic, and steric factors) are related to molecular structure, Dr. 
Schultz's group focuses on identifying global descriptors of such properties that are best 
- in modeling of uptake and interaction. Previous work by Dr. Schultz's group have shown 
that the site of action for toxic events is the cell membrane. In the case of covalent 
events, it is soft nucleophiles associated with membrane-bound proteins, whereas, in the 
- case ofnon-covalent events it is the fatty acids ofthe membrane lipid bilayer. 
This past year Dr. Schultz and his students have examined the ability of different
- molecular-orbital quantum-chemical parameters to quantify electrophilic reactivity. They 
have developed quantifiable chemical measurements for different types of interactions or 
bonding between the toxicant and its site ofaction.
-
-
Most recent work has focused on chemicals whose toxicity does not model well' 
by this descriptor. Julie Seward, a senior doctoral student supported in part by COE 
funding, has shown that certain aromatic chemicals follow a unique model. 
-
Other work in Biological Activity Testing and Modeling Laboratory has extended 
this approach to identify properties that best model toxic responses where interactions 
occur between the compound and a specific cell receptor. In the past year, this work 
focused on understanding the properties governing hormonal effects associated with the 
- human estrogen receptor. lbrough an examination of the estrogenic activity of a series 
of selected chemicals using the Saccharomyces crevice-based lac-Z reporter assay, Dr. 
Schultz and his colleague were able to characterize and quantify the potency of estrogens
- that occur in the environment. 
-
-
-
-
-
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-
Dr. Hildegard M. Schuller 

Fellows, Staff and Graduate Students: Dr. H. K. Plummer ill, Dr. Brian A. Jull, Dr. Y.

- Cakir, N. Neilsen, and K. Walker 
Lung cancer is the leading cause of cancer deaths in all industrialized countries. 
- East Tennessee has one of the highest lung cancer rates in the United States. Although 
cancers at other organ sites are more than twice as common, their cure rate is 
considerably higher. The most common cancer in men is prostate cancer, with a cure rate 
-
of 84%. Breast cancer is the leading type ofcancer in women with a cure rate of 74%. In 
contrast, 158,700 (89.3%) of the 177,700 patients diagnosed with lung cancer in the year 
1997 died within 12 months ofdiagnosis. 
-
Smoking and exposure to second-hand smoke are the most intensively studied and 
best-documented risk factors for the development of lung cancer. Contrary to cancers at 
-
other organ sites, the incidence of lung cancer continues to rise in all industrialized 
-
nations. Moreover, teen smoking in the U.S. has increased at an alarming rate, thus 
setting the stage for even higher numbers of lung cancer cases 30-40 years from now. 
Another important contributing factor to the rise in lung cancer cases is the growing 
number of lung cancers developing in individuals never exposed to primary or second­
hand smoke. This trend, which has been globally observed during the last two decades in -
all industrialized countries, is particularly evident for pulmonary adenocarcinoma. Ofthe 
six types of lung cancer recognized by the World Health Organization classification, two 
- (small-cell carcinoma and adenocarcinoma) accounts for 90% of all lung cancers, but 
30% ofthese cases do not have a history ofexposure to primary or second hand smoke. 
- The lung cancer "epidemic" is closely related to a globally observed rise in 
chronic lung diseases such as bronchitis, bronchiolitis, asthma, emphysema, and chronic 
obstructive pulmonary disease. This disease complex, which is often referred to as 
"allergies" has the same geographic distribution as lung cancer with which it shares some 
risk factors such as smoking and air pollution. Accordingly, East Tennessee, which has 
one of the highest lung cancer rates in the U.S., is also often referred to as ''the land of
- allergies." For all lung cancer types, chronic lung disease has been identified as a risk 
factor even without a history ofexposure to smoke. 
- Dr. Schuller's research has been dedicated to the study of lung cancer for over 20 
years. It is her belief that effective strategies for the prevention and therapy of this 
disease complex can only be based on an in-depth understanding of the regulatory 
- mechanisms which govern the growth of normal lung cells and the cancers arising from 
such cells. In contrast to other laboratories that are searching for the "magic molecular 
-
event" responsible for the genesis of all lung cancers, she hypothesized that different lung 
cell types and different types of lung cancer may be governed by different regulatory 
mechanisms, which in tum may be affected differently by known risk factors for the 
disease.
-
-
-
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.. Dr. Schuller's achievements in lung cancer research have been recognized 
nationally and internationally. Her research has been supported by the Center of 
Excellence, but her primary support comes from substantial grants of the National Cancer 
Institute and the pharmaceutical industry. 
.. 
Dr. Schuller's group previously determined that the growth of small cell lung 
.. 
carcinoma and the cell of origin of this cancer type (pulmonary neuroendocrine cell) is 
regulated by a specific cell surface receptor (nicotinic acetylcholine) which has an 
important biochemical function (calcium channel). She found also that the tobacco­
.. 
specific carcinogenic product (NNK) activates this receptor with high affinity. Binding 
of this product to the receptor causes a release of a biochemically active substance 
(serotonin) by these cells and that this substance markedly stimulates cell division when 
.. 
it is taken up by other cells. This is an important finding because it links, for the first 
time, the stimulation of a specific receptor by a tobacco-specific toxicant resulting in the 
activation of a series of cell-specific events that may result in uncontrolled growth . 
Experiments are now underway to test the hypothesis that substances which inhibit the 
re-uptake of serotonin will protect against the development and spread of small cell lung 
carcinoma. These drugs are already approved for the treatment of psychiatric diseases 
- and migraine and could immediately enter clinical trials in smokers and small cell 
carcinoma patients . 
.. 
Laboratory studies with various cultures of small cell lung cancer cells and 
pulmonary neuroendocrine cells suggest that smoking or chronic exposure to the product 
.. NNK., increases the concentration of the target receptors on these cells. Dr. Schuller now 
is working with Dr. Kabalka of the Department of Chemistry on the development of 
novel cancer imaging agents which selectively bind with high affinity to this receptor that 
.. will allow for a selective and highly sensitive detection ofsmall cell carcinomas in people 
(by positron emission tomography). This will constitute an important clinical application 
ofher research . 
.. 
-
-
-
-
.. 
.. 
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ANTICANCER MOLECULAR ONCOLOGY LABORATORY 
Dr. Hwa-Chain R. Wang 

Fellows: K. Fecteau, J. Mei, Y. Sun, M. Tan 

Dr. Wang's long-term research goals concerns tumor-specific intracellular
.. molecular signaling networks and to uncover signaling pathways that can be induced by 
anticancer agents to lead cancerous cells into programmed cell death (apoptosis). 
Short-term goals are to identify intracellular signaling elements whose activation 
-
is involved in induction of apoptosis or growth inhibition of cancer cells. A corollary to 
this is to identify novel anticancer agents, which may selectively induce apoptosis of
.. 
cancer cells while sparing normal cells. Ultimately, he expects to apply the 
understanding of intracellular signaling control to anticancer therapeutics and prevention. 
.. 
- Currently, Dr . Wang focuses on three projects. The first is to understand the 
molecular and cellular function of a family ofnovel intracellular enzymes (Krs and QIK), 
which are induced in resting cells and cells undergoing programmed cell death. The 
second is to study molecular and biological activities of a novel natural anticancer agent 
(FR901228), which selectively induces programmed cell death of cancer cells. The third 
is to study the molecular and biological roles of mutations in genes that control tumors 
... (suppressor genes - transforming growth factor beta receptor genes, TPR-ll and TPR-I) in 
the development ofhuman oral cancers. 
Dr. Wang has identified a family of novel enzymes (kinases: SAMKIKrsl and 
QIK) that are activated in normal resting cells and in cancerous cells undergoing 
programmed cell death (as a result of a variety of physiological, chemical or physical 
- stresses). Induction of QIK activity is involved in establishing cell quiescence but 
additional activation may result in cell death. He is investigating the molecular and 
biological roles of these enzymes in cancer development and programmed cell death. 
Uncovering the apparent novel signaling pathway that cross-links cancer development of 
cells to programmed cell death should be directly exploitable for development of 
.. anticancer therapeutics . 
Investigation into the molecular mechanisms of potential anticancer therapeutic 
agents on a variety of cancer cell types particularly human breast cancer cells is ongoing. 
- Cancerous mouse embryo cell cultures and various human tumor cell cultures are used to 
screen anticancer agents. Studies on the molecular effects of a novel natural anticancer 
agent (FR901228) on different intracellular metabolic signaling pathways should uncover 
the mechanism of this agent to selectively induce programmed cell death in cancerous 
cells. Dr. Wang determined that at least five important intracellular metabolic signaling 
-
pathways including the QIK pathway are affected. The information will be a basis for 
clinical trials using FR901228 in combination with other anticancer agents. 
The role of mutations in tumor suppressor genes (TfJR-ll and TPR-I genes) in the 
-
multi-stage development of human oral cancers will require the detection and analysis of 
... 
.. 

23 
--
.. 
.. 
-
the mutations in these genes isolated from pre-malignant and malignant cells of the oral 
cavity. Specific mutations in the TPR-II and TPR-I genes will be identified by their 
functional inability to transmit signals to suppress tumor formation. This research is a 
part of a major collaborative program project to study molecular events in progression 
and prevention of oral cancer . 
Dr. Wang's research is supported by the Center of Excellence, but his primary 
funding source is the National Institutes ofHealth (National Cancer Institute and National 
Institute ofDental Research). 
.. 
.. 
.. 
-
-
.. 
-
-
-
-
.. 
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CANCER MODELLING LABORATORY 
Dr. Michael McEntee 
.. Collaborators, Staffand Graduate Students: Dr. J. Whelan, A. Cruikshank, N. Neilsen 
-
Dr. McEntee's research focuses on defining the relationship between tissue levels 
of polyunsaturated fatty acids, their metabolism as bioactive lipids (such as prostaglandin 
-
E2), and forms of cancer to which they have been linked. In collaboration with a 
biochemist in the Department of Nutrition at UT, Dr. J. Whelan, he demonstrated 
recently that specific dietary polyunsaturated fatty acids can significantly protect against 
the development of intestinal cancer in a mouse model of the human disease. Non­
steroidal anti-inflammatory drugs like aspirin inhibit the metabolism of polyunsaturated 
fatty acids into various prostaglandins. Their research involved the simultaneous 
pharmacologic and dietary manipulation of tissue polyunsaturated fatty acids 
concentrations. 
Polyunsaturated fatty acids derived from fish oils reduced the incidence of this 
form of neoplasia by 50% in comparison to polyunsaturated fatty acids common in the 
- U.S. diet (Le. animal fat and vegetable oil). Their research suggested that this protective 
effect was specifically attributed to longer chain, highly unsaturated polyunsaturated fatty 
acids. Dr. McEntee also demonstrated for the frrst time in an animal that prostaglandins 
- produced from the "bad" tissue polyunsaturated fatty acids specifically contributes to 
intestinal tumor growth. Inhibition of the metabolism of polyunsafurated fatty acids 
found in com oil and red meat to prostaglandins significantly contributes to intestinal 
carcinogenesis. 
The importance of prostaglandins in production of tumors was subsequently
- confirmed in experiments where tumors were eliminated following treatment with an 
antibody that specifically inactivates this polyunsaturated fatty acid product. 
Prostaglandin E2 acts through specific cell receptors and they have shown that it is 
- produced by the non-neoplastic part of intestinal tumors of their mouse model (as it is in 
humans). They are currently attempting to characterize the distribution of the 
.. 	 prostaglandin E2 receptors in these lesions in order to better understand the link between 
the production/target activity of this specific bioactive lipid and intestinal carcinogenesis. 
Recent data suggest that the molecular changes contributing to intestinal carcinogenesis 
in humans and their mouse model also occur in pet dogs that develop this form of
- neoplasia. This strongly implies that the beneficial effects of dietary and pharmacologic 
intervention demonstrated in the mouse model would directly translate to dogs, as well as 
humans.
- In addition to the above experiments, studies have been initiated to investigate the 
contribution ofpolyunsaturated fatty acids and their metabolites to another common form 
ofneoplasia that has been strongly linked to dietary fats in humans, prostatic cancer. 
-
Dr. McEntee receives support from the Center of Excellence, but his primary 
funding is derived from the Department of Defense, American Institute of Cancer
- Research and Monsanto. 
-
-
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CELL BIOLOGY LABORATORY 
Dr. Xuemin Xu 
.. 
StafIand Graduate students: G. Mao, Ph.D., Y. Shi, W. Gao, and E. Laag 
The long-term goal of Dr. Xu's research is to understand the molecular and cellular
- mechanism of Alzheimer's disease, and the formation of senne plaques, the pathological 
hallmark of this disease. His group is conducting two projects. One is to determine the 
pathological function of a substance (presenilin 1) in brain degeneration and the genesis of another 
substance (amyloid) observed in Alzheimer's disease. The other project is to determine the role of a 
certain protein (apolipoprotein E) in the formation and clearance of another protein involved 
Alzheimer's disease Oi-amyloid peptide). 
-
Alzheimer's disease is a progressive degenerative disorder, characterized by memory loss, 
-
confusion, and a variety of cognitive disabilities. An estimated four million American suffer from 
Alzheimer's disease. It is the fourth major cause of death in the United States following heart 
disease, cancer, and stroke. Alzheimer's disease is the third most costly disease in the U.S. With 
the rapid growth of the senior population, Alzheimer's disease poses, besides its tragic personal 
- impact, serious problems to families, caregivers, government and health care in institutions. 
Molecular genetic analysis of familial (heritable) Alzheimer's disease has led to the
- identification of three Alzheimer's disease-causative genes, those of (i-amyloid precursor protein, 
presenilin 1, and presenilin-2. A fourth gene encoding apolipoprotein E has also been associated 
with Alzheimer's disease as a risk factor but not as a causative gene for Alzheimer's disease. 
- Among these Alzheimer's disease -causative genes, mutations in presenilin 1 gene account for the 
majority of the known cases of familial Alzheimer's disease. Presenilin 1 has been implicated in 
.. two pathological events: (1) the generation ofamyloid-(i peptide, which is the building block ofthe 
toxic "plaques" characteristic of brain tissue from patients with Alzheimer's disease, and (2) 
programmed cell death, or apoptosis, a natural process in which unneeded or worn-out cells 
commit suicide. However, questions regarding the mechanisms by which the mutations in 
-
presenilin 1 proteins alter (i-amyloid precursor protein processing and cause programmed cell 
death, as well as the normal function of presenilin 1, remain to be answered, which is the goal of 
their current research project. 
Recent work resulted in the identification of a novel molecule (pSAP) which is capable of
- inducing programmed cell death, one of the mechanisms of neuronal cell death observed in 
Alzheimer's disease brains. It reacts specifically with presenelin 1. This finding established for the 
first time the molecular link between presenelin 1 and programmed cell death. Currently, we are
- conducting the experiments to determine the role presenelin 1 has in regulating PSAP-induced 
programmed cell death and with other Alzheimer's disease protein structures such as amyloid 
plaques and neurofibrillary tangles. This study will contribute to understanding the pathological 
-
- function of presenilin 1 and will provide new insight into the mechanism of Alzheimer's disease. 
This study may also lead to the identification a new therapeutic target of Alzheimer's disease 
treatments. 
-
26 
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Dr. Xu's studies in exploring the role of apolipoprotein E in ~ amyloid peptide fonnation 
-- suggests that these substances bind together to fonn complexes that interfere with the function of 
a critical enzyme (l-secretase. The binding of apolipoprotein E to newly generated ~ amyloid 
peptide also may play a role in determining whether the latter is deposited or cleared. These 
- studies will lead to a better understanding of the mechanism by which the apolipoprotein E is 
involved in Alzheimer's disease. 
- Dr. Xu's experiments are conducted with laboratory models, including brain 

(glial) cells containing the genes of apolipoprotein E and for amyloid precursur protein 

and in a yeast two-hybrid system. Because mutations in the presenilin 1 gene are 

associated with the majority of familial Alzheimer's disease, these studies may provide 

important infonnation for the early diagnosis and therapy ofthis disease. 

- Dr. Xu's work is funded by grants from the National Institutes of Health, Sigma 
Kappa and by the Alzheimer's Association. He receives support also from the Center of 
Excellence.
-
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-... Dissemination of Research to the General Public 
Dr. Nancy Howell 
.. 
One important function of the Center of Excellence is to provide infonnation to 
the general public. This infonnation may increase the public's awareness of research and 
.. 
may provide individuals with valuable results that may improve their lives or their 
agribusiness. 
To distribute infonnation the College of Veterinary Medicine uses several -
.. 
methods. A general newsletter is distributed twice a year throughout Tennessee and 
beyond, highlighting research activities. Features concerning on-going research, in 
addition to results from concluded research projects, are included in the publication, 
Veterinary News, which is written for general audiences. Features also appear in other 
University of Tennessee publications, including UT Agriculture, UT Alumnus and
- Tennessee AgriScience. 
-
In addition, news releases are distributed to state media and to regional and 
national media. Television and print publications produce numerous features about the 
College each year, many related directly to research conducted through the Center of 
Excellence. Public displays about the College frequently include highlights of COE 
research. Center of Excellence researchers are invited to share their research not only 
professionally, but as speakers to commodity groups, civic groups and other interested 
individuals . ... 
Research is a component of the College's web site, including COE projects such 
as the tall fescue toxicity research and other research projects. 
Dissemination of research results through the news media helps infonn the public 
.. and provides citizens with a better understanding of the practical applications of science 
in their daily lives . 
... 

... 

.. 
-
... 
... 
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TABLEt 
CENTER OF EXCELLENCE IN LIVESTOCK DISEASES 
-
AND HUMAN HEALTH BENCHMARKS OF FACULTY ACCOMPLISHMENTS 
-
-
-
-
-
-
-
-
1999-2000 
Actual Average 
Number of: 
Articles 89 (5.24) 
Books or Book Chapters 10 (0.63) 
Published Proceedings 18 (1.13) 
Total Publications 117 (7.31) 
Abstracts 20 (1.25) 
Invited Participation at: 
Regional Meetings 53 (3.31) 
National Meetings 44 (2.75) 
Faculty in Center 16 
Number of Visitors 6 
-

... 

-

-

-
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TABLE 2 

RESEARCH PROJECTS FUNDED EXTERNALLY 

REPORT PERIOD 1999-2000 

PROJECT DIRECTOR 
Frank Andrews 
Josepb Bartges 
David Bemis 
TITLE OF GRANT 
Pathogenesis of acid injury in the glandular and 
non-glandular region of the equine stomach. 
Pathogenesis ofacid injury in the non-glandular 
region ofthe equine stomach. 
Funding for a summer veterinary student and a 
clinical project: Detennination ofmaintenance 
energy requirements of client-owned dogs 
Comparison oftwo dietary approaches for 
managing canine chronic renal failure 
Pentosan polysulfate sodium in the treatment of 
idiopathic feline lower urinary tract disease. 
Influence ofdiet on urine saturation with struvite in 
healthy cats 
Influence ofdiet on glycemic control in dogs with 
spontaneous insulin-dependent diabetes mellitus 
Influence of alkalinization on urinary saturation 
with calcium oxalate and struvite, and bone mineral 
density in cats 
APR studies 
Antibody response to Bordetella bronchiseptica 
chimeric fimbrial protein antigen 
FUNDING AGENCY 
Comparative Gastroenterology Society 
Research 
Grayson-Jockey Club Research 
Foundation 
Ralston Purina 
lams 
DVM Phannaceuticals 
Ralston Purina 
Ralston Purina 
Morris Animal Foundation 
Hills Pet Nutrition 
USDA 1433 Funds 
TOTAL AWARDED 
$5,000.00 
07/01/98-07/01/00 
$37,110.00 
04/01/99-03/31/01 
$10,000.00 
OS/24/99-08/31/00 
$29,522.00 
04/01/99-07/01/02 
$133,112.00 
09/12/97-08/31/01 
$9,594.00 
10/01/97-10/31/00 
$6,093.00 
1% 1/97 -10/31/00 
$25,000.00 
09/01/97-03/31/00 
$13,500.00 
11/01/97 -10/31/99 
$12,000.00 
10/01/98 - 09/30/99 
ESTIMATED 

EXPENDITURES 

o 
$24,035.58 
$2,091.86 
o 
$58,909.35 
$4,824.59 
$4,463.88 
$8,079.07 
o 
$2,354.31 
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I I 
• • 
David Brian 
Mei-Zben Cui 
James Godkin 
Stephen Kania 
Alan Mathew 
I I I 

Bovine coronavirus vector for mucosal immunity to 
phaemolytica leukotoxin 
Mechanism(s) ofcoronavirus RNA replication and 
packaging 
Scientist development award 
The role of retinol in oocyte maturation and early 
embryonic development. 
Serum neutralization ofbovine virus 
Laboratory tests for vaccine development 
Ophidian paramyxovirus infection 
A recombinant protein based TSH assay 
Effects ofenvironment and management on 
persistence ofantibiotic resistance in bacteria from 
swine 
Resistance patterns on swine farms using or 
excluding antimicrobial products 
Effect ofdrug combinations and regimens of 
antibiotic resistance 
I I I I I I 

USDA 
National Institute ofAllergies and 
Infectious Diseases 
American Heart Association 
USDA 
Pfizer 
Pfizer 
American Zoo & Aquarium Assoc 
American Kennel Club 
The International Life Science Institute 
National Pork Producers Council 
National Pork Producers Council 
I I I I 

$140,000.00 
09115195-09/30/00 
$586,309.00 
07/01196-06/30/01 
$240,000.00 
01/01198-12/31101 
$215,000.00 
09/01/99-08/31103 
$6,400.00 
$5,000.00 
7115199-7/31100 
$16,900.00 
10/01/98-9/30/00 
$33,796.00 
05101197-09/30/99 
$62,789.00 
09/01199-08/31100 
$22,490.00 
10/01198-12/31199 
$24,090.00 
10/01198·09/30/99 
I I I 

$55,444.58 
$70,420.63 
$48,889.97 
$19,969.00 
$6,887.54 
$13,701.21 
$11,739.49 
$28,220.00 
$18,771.00 
$15,549.00 
$1,812.00 
31 
I I I 
• • • • 
Michael McEntee 
John New 
Jack Oliver 
Effect ofn-3 and n-6 polyunsaturated fatty acids on 
growth and progression ofprostatic cancer in vivo 
In vivo effects of resveratrol during early stages of 
intestinal tumorigenesis 
Dietary effects ofa variety of fatty acid ethyl esters 
on the fonnation and development of intestinal 
polyps in the MinI+ mouse model when provided in 
the context of a western diet 
Delta-6 desaturase inhibition and intestinal 
tumorigenesis 
Role ofarachidonic acid and PGE2 as key 
mediators of intestinal tumorigenesis in vivo 
The feasibility ofbehavioral counseling to promote 
successful puppy adoptions 
The feasibility of behavioral counseling to promote 
successful puppy adoptions 
Reactivity ofbovine vasculature to Ergovaline and 
Ergine oftoxic tall fescue 
Assessment of inflammatory and immunologic 
response ofcattle to tall fescue toxins 
Pathophysiologic studies of tall fescue toxins in 
cattle 
DOD-Anny 
American Institute of Cancer Research 
Monsanto (Co-PI) 
Monsanto (Co-PI) 
American Institute ofCancer Research 
(Co-PI) 
Morris Animal Foundation 
PetsMart Charities 
USDA 
USDA 1433 Funds 
USDA 1433 Funds 
$312,938.00 
04/15/00-05/14/03 
$75,952.00 
07/01/99-06/30/01 
$71,656.00 
01/01/99-01/01/00 
$7,150.00 
6/99-1/00 
$158,484.00 
7/99-6/01 
$34,700.00 
07/16/97-06/30/99 
$10,000.00 
1% 1/97-09/30/99 
$188,000.00 
10/01197-09/30/00 
$3,000.00 
1% 1/98-9/30/99 
$6,000.00 
10/1/99-09/30/00 
$940.36 
$12,302.51 
$71,656.00 
$7,150.00 
$82,000.00 
$7,350.39 
0 
$87,731.35 
$500.00 
$389.31 
32 
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Stephen Oliver 
Sharon Patton 
Rapid, specific test for salmonella subtypes 
Safety specific immune responses and protection in 
experimentally infected dairy cows 
Reproductive performance and reproductive 
disorders in Jersey cows 
Development of chronic streptococcus uberis 
intramammary infections in lactating dairy cows 
Evaluation of specific immune responses and 
protection by streptococcal uberis antigens in 
naturally infected dairy cows 
Evaluation of the Uterine Environment During 
Clinical Mastitis in Lactating Jersey Cows 
Model for Determining Effects ofMastitis on 
Reproductive Performance in Jersey Cattle 
Evaluation and use ofBAMlFDA and rapid 
microbiological methods for on-farm surveys 
Field Test for Diagnosing Toxoplasma gondii in 
Swine 
National Pork Producer's Council 
Pfizer 
American Jersey Cattle Club 
Pharmacia and Upjohn 
Pfizer 
American Jersey Cattle Club 
American Jersey Cattle Club 
Food and Drug Administration 
National Pork Producer's Council 
$29,150.00 
06/01199-07/31100 
$165,000.00 
04/01/99-12/31/00 
$6,250.00 
04/01/99-04/01/00 
$56,258.00 
01101199-12131100 
$245,624.00 
06/01198-12/31199 
$5,500.00 
04/01100-04/01101 
$4,250.00 
04/01/99-03/31100 
$475,610.00 
09/30/98-09/29/01 
$18,435.00 
10/01/98-06/30/00 
$26,221.00 
$1,400.00 
$46,812.00 
$15,341.00 
$64,318.00 
$2,010.00 
$4,250.00 
$120,545.71 
$13,265.22 
33 
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• • • • 
Barry Rouse 
Hildegard Schuller 
Herpes zosterfilization 
Immunity mechanisms in herpesvirus infections 
Mechanisms of herpetic stromal keratitis 
Biodelivery sciences 
HSP peptide complexes as a putative vaccine 
against herpes simplex virus 
Vaccination against herpes simplex virus 
Transplacental pancreatic carcinogenesis by NNK 
Effects of the phosphodiesterase inhibitor B9302­
107 on the nasal cavity in hamsters, mice and rats 
FACS Vantage SE Cell SorterIFlow Cytometer 
Smith-Kline Biological 
National Institute of Allergy and 
Infectious Diseases NIH 
National Eye Institute - NIH 
BiodeJivery Sciences 
Antigenics Agency 
National Institute ofAllergy and 
Infectious Diseases- NIH 
National Institute ofHealth 
BYKGulden 
National Center for Research Resources 
$124,746.00 
open 
$1,065,526.00 
06/01/95-05/31100 
$246,205.00 
09/30/97-09/29/02 
$12,000.00 
open 
$16,620.00 
04/15199-04/14100 
$1,396,346.00 
03/01100-02128/05 
$1,001,479.00 
08/01196-07/31101 
$40,360.00 
04/01198-03/31100 
$150,000.00 
04/01/00-03/31101 
$8,572.72 
$225,460.14 
$205,778.43 
$3,252.27 
0 
0 
726,399.83 
$40,360.00 
0 
34 
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Terry Schultz 
David Slauson 
Carla Sommardahl 
Hwa-Chain Wang 
XueminXu 
TOTALS 
Development ofa bioremediation risk assessment 
scheme 
Microbial transformation and molecular toxicology 
of estrogens 
The Role ofbioavailability in determining 
acceptable limits for the bioremediation of 
polychlorinated biphenyls 
Ecotoxicity of organic chemicals 
Degradation ofnatural estrogens in wastewater 
treatment facilities 
Cellular Pathobiology ofEnvironmental Disease 
Molecular analysis ofPKD in the TGN737RPW 
mouse 
Pathway leads to apoptosis in SCR-transformed 
cells 
Biochemical evaluation ofthe functionality of 
mutated TBR-II and TBR-I receptors 
Role of APOE in beta amyloid formation 
Role ofapoE App processing 
Role ofapolipoprotein in AD amyloid formation 
US Environmental Protection Agency 
Water Resources Research Institute 
U.S. Department of Energy 
Proctor and Gamble 
University of Mississippi 
NIH 
NIH 
NIH 
Ohio State University 
Sigma Kappa 
Alzheimer's Association 
National Institute ofNeurological Disease 
and Stroke 
$59,199.00 
09/94-09/98 
$295,334.00 
12107/98-12/06/00 
$441,037.00 
01/01/97-05/31/00 
$6,600.00 
11/0199-10/31/01 
$25,400.00 
09/01/97-10/31/00 
$590,897.00 
07/01/95-06/30/00 
$385,901.00 
07/01/97-07/01/01 
$517,520.00 
01/01/98-12/31/02 
$192,453.00 
09/15/98-06/30/03 
$30,000.00 
11/01/98-10/31/00 
$80,000.00 
08/01/98-12/31/00 
$677,968.00 
05/01/99-04/30/02 
$10,863,253.00 
$20,000.00 
$64,036.00 
5160,053.00 
0 
$25,397.00 
$218,931.17 
$177,474.72 
$128,162.21 
$26,755.67 
$10,245.86 
$2,425.21 
$99,354.58 
$3,103,004.72 
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CENTERS OF EXCELLENCE/CENTERS OF EMPHASIS 

ACTUAL, PROPOSED, AND REQUESTED BUDGET 

Institution _..;:C:..::o;.:,;lI:.::;ega;e:..o;:;;f:....;V:....:e;.:;ter=ln:.;:a::...lryt,.;Med=::.:ic;;.:l::..:.ne~__________Center Livestock and Human Health 
1988-2000 Actual 2000-2001 Proposed 2001-2002 Requested 
Matching Appropr. Total Matching Appropr. Total Matching Appropr. Total 
Expenditures 260,550 521,100 781,650 265,250 530,500 795,750 278,082 557,456 835,538 
Salaries 
Faculty 28,544 57,220 85,764 37,463 75,099 112,562 31 ,672 63,492 95,164 
Other Professional 54,888 110,030 164,918 77,316 154,992 232,308 81 ,182 162,741 243,923 
ClericaV Supporting 12,303 24,662 36,965 9,762 19,570 29,332 10,250 20,548 30,799 
Assistantships 18,255 36,595 54,850 20,015 40,122 60,137 21,015 42,128 63,144 
Total Salaries 113,989 228,508 342,497 144,556 289,783 434,339 144,120 288,910 433,030 
Longevity 1,327 2,660 3,987 1,331 2,669 4,000 1,398 2,802 4,200 
Fringe Benefits 25,737 51,595 77332 31,792 63,731 95,523 31 ,695 63,538 95,233 
Total Personnel 141054 282,762 423818 177679 356,183 533,862 177,213 355,250 532483 
Non-Personnel 
Travel 1,126 2,258 3,384 1,331 2,669 . 4,000 0 0 0 
Software 0 0 0 0 0 0 0 0 0 
Books & Journals 0 0 0 0 0 0 0 0 0 
Other Supplies 41,627 83,446 125,073 50,112 100,457 150,569 34,333 68,824 103,157 
Equipment 37,785 75,746 113,531 62,369 125,029 187,398 52,558 105,360 157,918 
Maintenance 10,340 20,728 31,068 13,313 26,687 40,000 13,978 28,022 42,000 
Scholarships 2,129 4,267 6,396 3,328 6,672 10,000 0 0 0 
Consultants 0 0 0 0 0 0 0 0 
Renovation 0 0 0 0 0 0 0 0 0 
Other (Specify) 3,630 7,276 10,906 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 
Total Non-Peraonnel 96636 193722 290358 130454 261513 391,967 100869 202.206 303075 
GRAND TOTAL 237,690 476,484 714,174 308,133 617,696 925,829 278,082 557,456 835,538 
Revenue 
New State Appropriation 521 ,100 521,100 530,500 530,500 557,025 557,025 
vall YVy",. O!i:lltl 
Appropriation 42,104 42,104 86,720 86,719 0 
New Matching Funds 260,550 260,550 265,250 265,250 278,513 278,513 
varryover from PrevIous 
Matching Funds 21 ,050 21,050 43,360 43,360 0 
Total Revenue 281,600 563,204 844,804 308,610 617,220 925,829 278,513 657,025 835,538 
II. 

III 

